- Home
- LGND vs CRTO Comparison
LGND vs CRTO Comparison
Compare LGND & CRTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGND
- CRTO
- Stock Information
- Founded
- LGND 1987
- CRTO 2005
- Country
- LGND United States
- CRTO France
- Employees
- LGND N/A
- CRTO N/A
- Industry
- LGND Biotechnology: Pharmaceutical Preparations
- CRTO Advertising
- Sector
- LGND Health Care
- CRTO Consumer Discretionary
- Exchange
- LGND Nasdaq
- CRTO Nasdaq
- Market Cap
- LGND 2.2B
- CRTO 2.1B
- IPO Year
- LGND 1992
- CRTO 2013
- Fundamental
- Price
- LGND $120.67
- CRTO $41.85
- Analyst Decision
- LGND Strong Buy
- CRTO Buy
- Analyst Count
- LGND 6
- CRTO 10
- Target Price
- LGND $145.00
- CRTO $54.67
- AVG Volume (30 Days)
- LGND 79.6K
- CRTO 539.3K
- Earning Date
- LGND 02-27-2025
- CRTO 02-05-2025
- Dividend Yield
- LGND N/A
- CRTO N/A
- EPS Growth
- LGND 160.46
- CRTO 115.91
- EPS
- LGND 2.47
- CRTO 1.90
- Revenue
- LGND $152,422,000.00
- CRTO $1,933,289,000.00
- Revenue This Year
- LGND $26.86
- CRTO N/A
- Revenue Next Year
- LGND $14.95
- CRTO $8.53
- P/E Ratio
- LGND $48.82
- CRTO $23.08
- Revenue Growth
- LGND N/A
- CRTO N/A
- 52 Week Low
- LGND $67.72
- CRTO $32.00
- 52 Week High
- LGND $129.90
- CRTO $49.93
- Technical
- Relative Strength Index (RSI)
- LGND 59.36
- CRTO 50.07
- Support Level
- LGND $110.42
- CRTO $42.95
- Resistance Level
- LGND $119.26
- CRTO $47.25
- Average True Range (ATR)
- LGND 3.82
- CRTO 1.64
- MACD
- LGND 0.61
- CRTO 0.01
- Stochastic Oscillator
- LGND 81.35
- CRTO 49.56
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About CRTO Criteo S.A.
Criteo SA is an ad-tech company in the digital advertising market. Its technology, allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. The firm also provides technology allowing retailers to effectively manage their ad inventories and improve yield optimization.